Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,128 | -29,499 | -25,451 | -23,553 | -16,385 |
| Depreciation Amortization | 1,940 | 1,967 | 2,138 | 1,459 | 1,318 |
| Accounts receivable | -3,999 | -3,278 | -135 | -400 | -287 |
| Accounts payable and accrued liabilities | -637 | 135 | 1,537 | -575 | 773 |
| Other Working Capital | -2,667 | -2,455 | 436 | -1,203 | 1,445 |
| Other Operating Activity | 4,978 | 4,410 | -284 | 1,966 | -1,156 |
| Operating Cash Flow | $-19,513 | $-28,720 | $-21,759 | $-22,306 | $-14,292 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -688 | -910 | -973 | -2,932 | -1,656 |
| Purchase Of Investment | 0 | -4,511 | -6,286 | -1,990 | -500 |
| Sale Of Investment | 0 | 10,797 | 500 | 1,987 | 8,899 |
| Other Investing Activity | 0 | 625 | 19 | -8 | 95 |
| Investing Cash Flow | $-688 | $6,001 | $-6,740 | $-2,943 | $6,838 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,510 | 10,000 | 5,000 | 13,000 | 14,651 |
| Debt Repayment | -1,034 | -3,855 | -3,503 | -4,000 | -1,745 |
| Common Stock Issued | 53 | 180 | 147 | 190 | 46 |
| Common Stock Repurchased | N/A | N/A | N/A | -69 | N/A |
| Other Financing Activity | 7,410 | 0 | 35,911 | 22,003 | 10,042 |
| Financing Cash Flow | $16,939 | $6,325 | $37,555 | $31,124 | $22,994 |
| Exchange Rate Effect | 68 | 113 | 3 | -19 | -2 |
| Beginning Cash Position | 17,796 | 34,077 | 25,018 | 19,162 | 3,624 |
| End Cash Position | 14,602 | 17,796 | 34,077 | 25,018 | 19,162 |
| Net Cash Flow | $-3,194 | $-16,281 | $9,059 | $5,856 | $15,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,513 | -28,720 | -21,759 | -22,306 | -14,292 |
| Capital Expenditure | -799 | -910 | -973 | -2,932 | -1,656 |
| Free Cash Flow | -20,312 | -29,630 | -22,732 | -25,238 | -15,948 |